Pragmatic analytical development lead with strength in oligonucleotide and small molecule analyses. Thorough knowledge of developing phase appropriate control strategies, supporting CMC and regulatory filings. Extensive experience in managing CDMOs, method development/transfer/validation, and testing review. Solution-oriented thinker who resolves challenges with strategic planning, strong sense of urgency and attention to detail.